Radiology 2012; 265:780–789 Departments of Radiology Kanazawa University Graduate School of Medical Science Azusa Kitao, MD et al. R3 Kwon Young Ho.

Slides:



Advertisements
Similar presentations
Joint Hospital Surgical Grand Round
Advertisements

High Intensity Focused Ultrasound (HIFU) for Liver Tumour Dr Dai Wing Chiu Queen Mary Hospital.
 Matthew M. Yeh, MD, PhD, Anne M. Larson, MD,w Jean S. Campbell, PhD,  Nelson Fausto, MD, Stephen J. Rulyak, MD,w and Paul E. Swanson, MD.
Jihye Choi June. Introduction Hepatitis B virus -Four overlapping reading frames -S: the viral surface proteins -P: viral polymerase.
Is the BRAF V600E mutation useful as a predictor of preoperative risk in papillary thyroid cancer? The American Journal of Surgery.
JHSGR 16 th April 2011 Dr Lee Man Kit Derek.  The value of PET in staging adenocarcinoma (e.g. colorectal cancer) is well established Tomoharu T. et.
Ayman Abdo MD, AmBIM, FRCPC
Maarten van Leeuwen, Joost Nederend and Robin Smithuis
Case Report # 1 Submitted by:Austen W. Worsham, MSIV Faculty reviewer: Dr. Oldham Date accepted: 8/29/2007 Radiological Category:Principal Modality (1):
Breast Cancers With Brain Metastases are More Likely to be Estrogen Receptor Negative, Express the Basal Cytokeratin CK5/6, and Overexpress HER2 or EGFR.
HCC Guidelines and recommendation Typical feature (wash in/wash out) New mass/nodule NoYes Alternative imaging technique Atypical featureTypical.
Consultant Radiologist Prince Sultan Military Medical City
Guzman, Alexander Joseph Hipolito, April Lorraine
Case Report Patient PP Submitted by:Matthew Clower, MSIV Faculty:Sandra Oldham, MD Date:29 August 2007 Radiological Category:Principal Modality (1): Principal.
Diagnosis of HCC History & PE Serologic Assays Radiology
ACRIN 6673 Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma in Cirrhotic Patients: A Multi-Center Study.
Journal meeting. Tumor heterogeneity Purpose: The aim of this study was to comprehensively characterize morphological intratumor heterogeneity in HCC.
Diagnosis. Multifactorial pathogenesis of HCC Normal liver HepatitisCirrhosisHCC Cell death Regeneration Persistent/chronic hepatitis Fibrosis HBV HCV.
Case Report # 1 Submitted by:James Korf, MS4 Faculty reviewer:Sandra Oldham, MD Date accepted:27 August 2014 Radiological Category:Principal Modality (1):
LUNG ADENOCARCINOMAS. CLINICOPATHOLOGICAL STUDY WITH RESPECT TO THE UPCOMING NEW CLASSIFICATION AND EGFR-KRAS MUTATION ANALYSIS IMPLICATIONS. First author:
Hamid Tavakkoli, MD Associate Prof. of Gastroenterology.
First author: Roman Adina Co-author: Andone Sebastian
INCREASED EXPRESSION OF PROTEIN KINASE CK2  SUBUNIT IN HUMAN GASTRIC CARCINOMA Kai-Yuan Lin 1 and Yih-Huei Uen 1,2,3 1 Department of Medical Research,
April 2014 Dr J King Dr K Syred.  90% mesotheliomas are linked to asbestos exposure  May be eligible for compensation  3 yr survival rate 8%  Subtype.
HCC Guidelines
SYB Case #2 Jordan Torok Class of 2010 December 11 th, 2008.
The Royal Marsden Solitary fibrous tumours The outcomes of 106 patients illustrating the unpredictable biological behaviour N Alexander, K Thway, JM Thomas,
Pancreatic Tumors in Children Presented by Damien W. Carter, MD.
Eun Sun Jang, M.D., Ph.D Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine Diseases.
Digestive system Diagnostic imaging department of xuzhou medical college of xuzhou medical college.
 Macroscopic anatomy › External view › The quadrate lobe belongs anatomically to the right lobe and functionally to the left
Hamid Tavakkoli, MD Associate Prof. of Gastroenterology.
Treatment Strategy for Recurrent Hepatocellular Carcinoma: Salvage Transplantation, Repeated Resection, or Radiofrequency Ablation? Albert C. Y. Chan,
Imaging of Focal Nodular Hyperplasia: A Review
Thomas Sersté1,2, Vincent Barrau3, Violaine Ozenne1, Marie Pierre Vullierme3, Pierre Bedossa5,6, Olivier Farges4, Dominique-Charles Valla1,6, Valérie Vilgrain3,6,
Management of Hepatocellular carcinoma
INTRODUCTION & OBJECTIVES Introduction: The carcinogenesis of hepatocellular carcinoma (HCC) is a multifactorial, multistep and complex process. Its prognosis.
The role of regulatory B cells on hepatocellular carcinoma progression Conclusion Results Fig2. (A and B) In vivo, Bregs in SCID mice increased the size.
HCC with bile duct tumor thrombi (HCC c BDTT) disease review 1.
University of Pennsylvania Department of Orthopaedic Surgery Joseph King, Eileen Crawford, Abass Alavi, Arthur Staddon, Lee Hartner, Richard Lackman and.
Differential Diagnosis
Nodules & Tumors Nodular Hyperplasia non-cirrhotic liver nodules
Comparison between Pathologic Characteristics of Her2 Negative and Positive Breast Cancer in a Single Cancer Center in Jordan DR Majdi A. Al Soudi, MD,
Discussion & Conclusion Predictives of Meningioma Grading
The Value of Measurement of Circulating Tumor Cells in Hepatocellular Carcinoma Nashwa Sheble, Gehan Hamdy, Moones A Obada, Gamal Y Abouria, Fatma Khalaf.
D.Ferguson, M.Mohammed, C. Healy, A.C. Harris, S Chang.
Cancer Hospital & Institute, Chinese Academy of Medical Sciences
Radiologic Findings CT US MR
Spontaneous Massive Necrosis of Hepatocellular Carcinoma with Narrowing and Occlusion of the Arteries and Portal Veins Case Rep Gastroenterol 2014;8:
Clinical features of resected hepatocellular carcinoma emerging after sustained virological response against chronic hepatitis C Hepato-biliary-pancreatic.
Case Rep Gastroenterol 2013;7: DOI: /
Fig. 1c: Cystoprostatectomy specimen
Daniela Sia, Augusto Villanueva, Scott L. Friedman, Josep M. Llovet 
MR of Liver imaging :How I do it?
An avidly enhancing mass is seen in the left lobe on arterial-phase imaging. It is slightly hyperintense on portal-venous-phase imaging but overall isointense.
Valérie Vilgrain, Bernard E. Van Beers, Catherine M. Pastor 
Liver Masses: A Clinical, Radiologic, and Pathologic Perspective
Hepatic adenomatosis in liver cirrhosis
Fig. 3. Sub-centimeter-sized HCC in 56-year-old man with chronic hepatitis B. Gadoxetic acid-enhanced MR image demonstrates 0.8-cm nodule (arrows) in right.
Primovist, Eovist: What to expect?
Daniela Sia, Augusto Villanueva, Scott L. Friedman, Josep M. Llovet 
Volume 124, Issue 1, Pages (January 2003)
Functional imaging in liver tumours
Jean-Charles Nault, Peter R. Galle, Jens U. Marquardt 
Fig. 2. HCC in 82-year-old man with chronic hepatitis C. A-C
Does Liver Regeneration Increase the Postoperative HCC Recurrence after Curative Resection ? Jin-Ho Lee, MD. Department of Surgery, Yonsei University.
Primovist, Eovist: What to expect?
Fig. 4. Gadoxetic acid-enhanced MRI in 62-year-old man with CHB
Volume 67, Issue 5, Pages (November 2017)
Fig. 3. Images of 54-year-old man with no arterial enhancement of HCC in arterial phase CT images.A. Unenhanced CT showed 2.9-cm HCC (asterisk) in segment.
Presentation transcript:

Radiology 2012; 265:780–789 Departments of Radiology Kanazawa University Graduate School of Medical Science Azusa Kitao, MD et al. R3 Kwon Young Ho

 Gadoxetic acid–enhanced MR  new imaging modality with high accuracy for diagnosing HCCs  hepatobiliary phase  HCCs  hypointensity (compared with background liver) preArterial phase 20 min delayed phase3min delayed phase

Magnetic Resonance Imaging 29 (2011) 83–90 preArterial phase 20 min delayed phase 3min delayed phase

 6%–15% of hypervascular HCC  iso- or hyperintensity  due to overexpression of organic anion transporting polypeptide 8 (OATP8) Radiology 2010; 256:817–826

HCC Signal intensity on hepatobiliary phase OATP8 (+) (-) hepatocyte nuclear factor Tumor marker AFP (L-3) PIVKA-II Histologic degree and prognosis ? ?

Materials and Methods- Patients  207 consecutive patients who had 233 HCCs  surgically resected at our institution and six affiliated institutions - April 2008 to September 2011  Excluded pts.  more than one HCC (12 pts with 31 nodules)  previous treatment (3 pts with 10 nodules)  not have MR imaging (9 pts with nine nodules)  hypovascular in arterial phase (3 pts with three nodules)

Analysis of SI on Gadoxetic Acid–enhanced MR Images  By two abdominal imaging radiologists  SI of the tumor and surrounding background liver  Average size of ROI  mm 2 ± (range, 61–6167 mm 2 ). Hypointense HCC (tumor SI/background SI< 1.0) Hyperntense HCC (tumor SI/background SI> 1.0)

Histologic Diagnosis  H-E staining carried out in all 180 liver specimens  compared hypointense HCCs and hyperintense HCCs Regard to histologic features Macroscopic growth patterns indistinct margin, simple nodular, extranodular growth, and multinodular patterns Differentiation grade well, moderately, and poorly differentiated Proliferation pattern trabecular, pseudoglandular, scirrhous, and compact pattern Fibrous capsule invasion, portal vein invasion and hepatic vein invasion

Immunohistochemical Analysis of AFP, PIVKA-II, and OATP8  Two abdominal imaging radiologists  intensity of the AFP and PIVKAII expression on tumor cytoplasm  intensity of OATP8 expression on tumor cellular membranes  analyzed the average grades of the two investigators AFP and PIVKAII expression grade 0no expression grade 1weak expression grade 2moderate expression grade 3strong expression intensity of OATP8 expression grade 0no expression grade 1decreased expression grade 2equivalent expression grade 3increased expression

Recurrence and Survival Rates in Patients with HCC  Compared the two groups for recurrence and survival  including all local recurrence and intrahepatic and extrahepatic metastasis  Follow-up length  727 days ± 365 (range, 22–1293 days)

moderately differentiated HCC with trabecular proliferation pattern moderately differentiated HCC with fat deposition serum AFP level, 23 mg/L; AFP-L3, 5.8%; PIVKA-II 30,mAU/mL OATP8 AFP PIVKA-II serum AFP level, mg/L; AFP-L3, 48.7%; PIVKA-II, 7924 mAU/mL

Results

P =.039 P =.07 P <.001 P =.003P =.026P =.004

Results

Discussion  We suspect that the molecular regulatory mechanism  some common channels  OATP8 expression ∝ 1/ AFP or PIVKA-II expression  Several prior reports  suggested that transcription factor hepatocyte nuclear factors control both OATP8 and AFP expression  However, many pts  low AFP and PIVKA-II expression in hypointense HCCs  OATP8, AFP, and PIVKA-II - several direct and indirect regulatory mechanisms

Discussion  Molecular classification of subtypes of HCCs  Yamashita et al  classified on the basis of expression of AFP and epithelial cell adhesion molecule (stem cell marker)  AFP-(+) and epithelial cell adhesion molecule–(+) HCCs  stem and progenitor cell features with invasive character and poor prognosis  compared with negative  mature hepatocyte-like features with relatively good px.  resembled hyperintense HCCs  Surmised origin of hyperintense HCC  mature hepatocyte-like cells

CONCLUSION  Hyperintense HCCs on hepatobiliary phase images  Significantly higher differentiation grades, less frequent portal vein invasion, and lower recurrence rates  Significantly lower expression of AFP and PIVKA-II  Particular form of hypervascular HCC with biologically less aggressive features than those of hypointense HCCs